id
processing priority
4
site type
3 (personal blog or private political site, e.g. Blogspot, Substack, also small blogs on own domains)
review version
11
html import
20 (imported)
first seen date
2024-09-26 23:25:17
expired found date
-
created at
2024-09-26 23:25:17
updated at
2026-02-08 16:40:11
length
27
crc
63479
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
69893241 (blogspot.com)
previous id
0
replaced with id
0
related id
-
dns primary id
0
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
58282
mp size raw text
4018
mp inner links count
5
mp inner links status
20 (imported)
title
Part Processing
description
image
site name
author
updated
2026-02-07 10:12:04
raw text
Part Processing Tuesday 4 October 2011 Neostem's PCT Accessory Signs Accomplishment Acceding With Immunocellular NeoStem (AMEX:NBS) said Monday that its accessory Progenitor Corpuscle Therapy (PCT) has active a accomplishment accord with clinical-stage biotech aggregation ImmunoCellular Therapeutics (OTCBB:IMUC). Under the acceding of the agreement, Progenitor's ability will serve as the additional accomplishment website to aftermath ImmunoCellular's ICT-107, a axis corpuscle vaccine which the Los-Angeles biotech aggregation is developing to action an advancing blazon of academician cancer, for a appearance two trial. As allotment of the deal, Progenitor will alteration and authorize the cGMP accomplishment action for ICT-107 at its West Coast ability in Mountain View, California, for use in ImmunoCellular's US-based appearance two trial, as able-bodied as approaching studies and development efforts. "We are actual aflame to access into this acceding with ImmunoCellular Therape...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
3281
text words
565
text unique words
282
text lines
42
text sentences
18
text paragraphs
6
text words per sentence
31
text matched phrases
4
text matched dictionaries
4
links self subdomains
0
links other subdomains
0
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
21 - blogger.com
links ext klim
0
links ext generic
1
dol status
0
dol updated
2026-02-07 10:12:04
rss status
32 (unknown)
rss found date
2024-09-26 23:25:20
rss size orig
9397
rss items
2
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
40 (completed successful import of reports.txt file to table in_pages)
sitemap review version
2
sitemap urls count
2
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-09-26 23:25:18
sitemap process date
2024-09-26 23:25:20
sitemap first import date
-
sitemap last import date
2025-12-28 20:45:11